These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4812836)

  • 1. 7-Substituted actinomycin D (NSC-3053) analogs as fluorescent DNA-binding and experimental antitumor agents.
    Modest EJ; Sengupta SK
    Cancer Chemother Rep; 1974; 58(1):35-48. PubMed ID: 4812836
    [No Abstract]   [Full Text] [Related]  

  • 2. Carbon-7 substituted actinomycin D analogues as improved antitumor agents: synthesis and DNA-binding and biological properties.
    Sengupta SK; Anderson JE; Kelley C
    J Med Chem; 1982 Oct; 25(10):1214-9. PubMed ID: 7143358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The stereochemistry of actinomycin binding to DNA.
    Sobell HM
    Cancer Chemother Rep; 1974; 58(1):101-16. PubMed ID: 4130352
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of peptide analogs of actinomycin D (NSC-3053).
    Meienhofer J
    Cancer Chemother Rep; 1974; 58(1):21-34. PubMed ID: 4812835
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis of an actinomycin analog with substituted lactone oxygens (1',1'-bis(L-,-diaminopropionic acid))-actinomycin C (C 1).
    Meienhofer J; Patel RP
    Int J Protein Res; 1971; 3(6):347-50. PubMed ID: 5289931
    [No Abstract]   [Full Text] [Related]  

  • 6. 7-substituted actinomycin D analogs. Chemical and growth-inhibitory studies.
    Sengupta SK; Tinter SK; Lazarus H; Brown BL; Modest EJ
    J Med Chem; 1975 Dec; 18(12):1175-80. PubMed ID: 1059773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of 7-substituted actinomycin D analogs with DNA.
    Sengupta SK; Schaer D
    Biochim Biophys Acta; 1978 Nov; 521(1):89-100. PubMed ID: 568940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. History and chemistry: modification of the actinomycin molecule.
    Brockmann H
    Cancer Chemother Rep; 1974; 58(1):9-20. PubMed ID: 4130362
    [No Abstract]   [Full Text] [Related]  

  • 9. Enantiomers of 7-(2,3-epoxypropoxy)actinomycin D as dual-action DNA-acting antitumor agents.
    Sengupta SK; Rosenbaum DP; Sehgal RK; Almassian B; Blondin J
    J Med Chem; 1988 Aug; 31(8):1540-7. PubMed ID: 3397991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N2- and C-7 substituted actinomycin D analogues: synthesis, DNA-binding affinity, and biochemical and biological properties. Structure-activity relationship.
    Sengupta SK; Anderson JE; Kogan Y; Trites DH; Beltz WR; Madhavarao MS
    J Med Chem; 1981 Sep; 24(9):1052-9. PubMed ID: 6169834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic and antitumor activity of 1-nitroacridines as an aftereffect of their interstrand DNA cross-linking.
    Pawlak K; Pawlak JW; Konopa J
    Cancer Res; 1984 Oct; 44(10):4289-96. PubMed ID: 6467190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intercalating drugs: DNA binding and molecular pharmacology.
    Wilson WD; Jones RL
    Adv Pharmacol Chemother; 1981; 18():177-222. PubMed ID: 6172965
    [No Abstract]   [Full Text] [Related]  

  • 13. DNA modification and cancer.
    Waring MJ
    Annu Rev Biochem; 1981; 50():159-92. PubMed ID: 6168236
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro and in vivo antitumor effects of novel actinomycin D analogs with amino acid substituted in the cyclic depsipeptides.
    Zhang BZ; Wang KR; Yan JX; Zhang W; Song JJ; Ni JM; Wang R
    Peptides; 2010 Apr; 31(4):568-73. PubMed ID: 20045716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actinomycin D oxazinones as improved antitumor agents.
    Sengupta SK; Trites DH; Madhavarao MS; Beltz WR
    J Med Chem; 1979 Jul; 22(7):797-802. PubMed ID: 448678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular models of DNA binding with antineoplastic antibiotics specific for certain DNA bases].
    Krylov AS
    Antibiotiki; 1982 Mar; 27(3):221-34. PubMed ID: 6284020
    [No Abstract]   [Full Text] [Related]  

  • 17. Investigation of the drug binding properties and cytotoxicity of DNA-capped nanoparticles designed as delivery vehicles for the anticancer agents doxorubicin and actinomycin D.
    Alexander CM; Dabrowiak JC; Maye MM
    Bioconjug Chem; 2012 Oct; 23(10):2061-70. PubMed ID: 23043330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some determinants of the therapeutic efficacy of actinomycin D (NSC-3053), adriamycin (NSC-123127), and daunorubicin (NSC-83142).
    Schwartz HS
    Cancer Chemother Rep; 1974; 58(1):55-62. PubMed ID: 4521481
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interactinos of DNA with low molecular weight ligands of various structures. I. Complexes of DNA with actinomycin and its simple analogs].
    Krivtsova MA; Moroshkina EB; Khamman Kh; Glibin EN; Frisman EV
    Mol Biol (Mosk); 1981; 15(3):613-21. PubMed ID: 7254212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of furamidine analogues in tumor cells: targeting of the nucleus or mitochondria depending on the amidine substitution.
    Lansiaux A; Tanious F; Mishal Z; Dassonneville L; Kumar A; Stephens CE; Hu Q; Wilson WD; Boykin DW; Bailly C
    Cancer Res; 2002 Dec; 62(24):7219-29. PubMed ID: 12499262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.